Invesco
PROF

Invesco’s Profound Medical PROF Stock Holding History

Invesco’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
+15,454
New +$104K ﹤0.01% 3729

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Invesco's PROF Position: Q2 2026 in Review

Invesco opened a new position in Profound Medical (PROF) in Q2 2026: 15,454 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #3729 among its holdings.

56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Invesco held 15,454 shares of Profound Medical worth $103K as of Q2 2026.
  • Profound Medical was a new Invesco position in Q2 2026.
  • Profound Medical made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3729 holding.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.